Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
Enoxaparin anticoagulation appears to be feasible for VV ECMO patients without an increase in adverse events. Further larger-sampled and comparative studies are needed in the future to support our findings.
Authors
- Miroslav Durila (ORCID: https://orcid.org/0000-0002-9515-8235)
- Michal Hlaváček (ORCID: https://orcid.org/0000-0002-9495-2082)
- Jaromír Vajter (ORCID: https://orcid.org/0000-0001-6277-2151)
- Jan Beroušek (ORCID: https://orcid.org/0000-0001-5405-1469)
- Robert Lischke (ORCID: https://orcid.org/0000-0002-0578-1833)
- Tomáš Vymazal (ORCID: https://orcid.org/0000-0003-1618-6252)
- Michal Garaj (ORCID: https://orcid.org/0009-0007-1943-1715)
Institutions
- Charles University (CZ)
- University Hospital in Motol (CZ)
Publication Details
- Journal
- Artificial Organs
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1111/aor.14879
- Citations
- 3
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.55